Although there are some clinical justification and applications in regulating NAD level in several diseases [51,56], such as CD38 inhibitors for boosting NAD in children with spectrum disorders [57], the evidence for NAD and MDD is still limited. The gene discussed is CD38; the disease is major depressive disorder.